| Home > Zentren > Zentrum für Diagnostik > Institut für Klinische Chemie / Zentrallaboratorien > Publikationen > 2007
Originalarbeiten
Klebig F, Fischer C, Petri S, Gerull H, Wagener C, Tschentscher P.
Limitations in molecular detection of lymph node micrometastasis from colorectal cancer.
Diagn Mol Pathol. 2007 Jun;16(2):91-5.
Poliani PL, Mitola S, Ravanini M, Ferrari-Toninelli G, D'Ippolito C, Notarangelo LD, Bercich L, Wagener C, Memo M, Presta M, Facchetti F.
CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation.
J Pathol. 2007 Apr;211(5):541-9.
Liu W, Wei W, Winer D, Bamberger AM, Bamberger C, Wagener C, Ezzat S, Asa SL.
CEACAM1 impedes thyroid cancer growth but promotes invasiveness: a putative mechanism for early metastases.
Oncogene. 2007 Apr 26;26(19):2747-58. Epub 2006 Oct 23.
Thies A, Berlin A, Brunner G, Schulze HJ, Moll I, Pfüller U, Wagener C, Schachner M, Altevogt P, Schumacher U.
Glycoconjugate profiling of primary melanoma and its sentinel node and distant metastases: amplications for diagnosis and pathophysiology of metastases.
Cancer Lett. 2007 Apr 8;248(1):68-80. Epub 2006 Jul 5.
Warnholtz A, Ostad MA, Heitzer T, Thuneke F, Fröhlich M, Tschentscher P, Schwedhelm E, Böger R, Meinertz T, Munzel T.
AT1-receptor blockade with irbesartan improves peripheral but not coronary endothelial dysfunction in patients with stable coronary artery disease.
Atherosclerosis. 2007 Oct;194(2):439-45. Epub 2006 Sep 12.
Lewerenz J, Ding X, Matschke J, Schnabel C, Emami P, von Borczykowski
D, Burchert R, Krieger T, de Wit M, Münchau A.
Dementia and leukoencephalopathy due to lymphomatosis cerebri.
J.Neurol Neurosurg Pychiatry. 2007 Jul; 78(7): 777-8 Epub Jan 8
Bogoevska V, Nollau P, Lucka L, Grunow D, Klampe B, Uotila LM, Samsen A, Gahmberg CG, Wagener C.
DC-SIGN binds ICAM-3 isolated from peripheral human leukocytes through Lewis x residues. Glycobiology 2007 Mar; 17 (3): 324-33
Machida K, Thompson CM, Dierck K, Jablonowski K, Kärkkäinen S, Liu B, Zhang H, Nash PD, Newman DK, Nollau P, Pawson T, Renkema GH, Saksela K, Schiller MR, Shin DG, Mayer BJ.
High-throughput phosphotyrosine profiling using SH2 domains.
Mol Cell . 2007 Jun 22; 26 (6): 899-915
Görg M, Wilck W, Granitzny B, Suerken A, Lukacs Z, Ding X,
Schulte-Markwort M, Kohlschütter A.
Stabilization of Juvenile Metachromatic Leukodystrophy after Bone Marrow
Transplantation: A 13-year Follow-up. J. Child Neurol, 2007, 22, 1139-1142
Schwedhelm E, Maas R, Freese R, Jung D, Lukacs Z, Jambrecina A,
Spickler W, Schulze F, Böger R.H.
Pharmacokinetic and Pharmacodynamic Properties of Oral L-Citrulline and
L-Arginine: Impact on Nitric Oxide Metabolism. Br J Clin Pharmacol, 2007, 65,
51-59
Ho S, Lukacs Z, Hoffmann G.F., Lindner M, Wetter T.
Using feature construction to improve diagnostic criteria for high
dimensional metabolic data in newborn screening for medium chain acyl-CoA
dehydrogenase deficiency (MCADD). Clin Chem, 2007, 53, 1330-1337
Lukacs Z, Hartung R, Beck M, Keil A, Mengel, E.
Direct comparison of enzyme measurements from dried blood and leukocytes
from male and female Fabry disease patients. J Inherit Metab Dis, 2007, 30,
614 (+ Suppl. Material Online)
Stellmer F, Keyser B, Burckhardt B.C., Koepsell H, Streichert, T,
Glatzel M, Jabs S, Thiem J, Herdering, W, Koeller D.M., Goodman
S.I., Lukacs Z, Ullrich K, Burckhardt G, Braulke T, Mühlhausen C.
3-Hydroxyglutaric acid is transported via the sodium-dependent dicarboxylate
transporter NaDC3. J Mol Med, 2007, 85, 763-770
 |
Publikationen nach Jahren |
